Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.
about
Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@en
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@nl
type
label
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@en
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@nl
prefLabel
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@en
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@nl
P2860
P356
P1476
Two Phase 1, Open-Label, Singl ...... ent Administration Conditions.
@en
P2093
Helen S Pentikis
Nikki Adetoro
P2860
P356
10.1002/CPDD.406
P577
2017-11-10T00:00:00Z